Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial is a research paper published in Clinical Breast Cancer (2021). On theSindex it has a DataRank of 0.413. It has been cited 10 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.0531
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
National Cancer Institute
Grant: U10CA180821
National Cancer Institute
Grant: U10CA180882
National Cancer Institute
Grant: U24CA196171
NCI NIH HHS
Grant: P30 CA015083
Genentech
Breast Cancer Research Foundation
Fondation Cancer
National Institutes of Health
Genomic Health
FWCI
0.88
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals